MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Solution

国药准字H20249565

December 1, 2024

Drug Information

吸入用硫酸沙丁胺醇溶液

吸入制剂

2.5ml:5mg(按C₁₃H₂₁NO₃计)

化学药品

December 1, 2024

Company Information

Applicant Company

山东费县北外环路1号

Manufacturing Company

山东省聊城市茌平区振兴街道华鲁街1号

© Copyright 2025. All Rights Reserved by MedPath